These results suggest that TNBS treatment may cause cognitive impairment with neuroinflammation by inducing hippocampal NF-κB activation and suppressing LPS-hippocampal BDNF expression through an increase in the brain–blood barrier permeability of LPS. This evidence concerns the gene NFKB1 and Cognitive impairment.